Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
The objective of this clinical trial is to evaluate the effectiveness of pelvic floor therapy for the management of erectile dysfunction and premature ejaculation in patients with erectile dysfunction and premature ejaculation. The main question to answer is: What is the effectiveness of pelvic floor therapy (electrostimulation, biofeedback, and therapeutic exercise) for the treatment of patients with erectile dysfunction and or premature ejaculation? Patients will: * Have an initial consultation of pelvic floor rehabilitation before therapy. * Be given pelvic floor therapy. * Have a secondary consultation of pelvic floor rehabilitation after therapy. Three intervention groups will be included: Group 1: Patients with premature ejaculation Group 2: Patients with erectile dysfunction Group 3: Patients with erectile dysfunction and premature ejaculation.
⁃ Overall:
• Men over 18 years of age
• Erectile dysfunction or premature ejaculation for at least 6 months
• Sexual activity with a heterosexual partner at least once a week
• Signing of informed consent before the start of the study
⁃ For the premature ejaculation group:
• Premature ejaculation according to the International Society of Sexual Medicine (ISSM) criteria
• Premature Ejaculation Diagnosis Tool (PEDT) questionnaire score greater than 11
⁃ For the erectile dysfunction group:
• Clinical diagnosis of primary erectile dysfunction
• International Index Erectile Function - Erectile Function domain (IIEF-EF) score less than 26